These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14709956)

  • 21. Zuclopenthixol acetate in a demented elderly patient with agitation.
    Myronuk L; Geizer M; Ancill RJ
    Can J Psychiatry; 1997 Apr; 42(3):325. PubMed ID: 9114954
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation.
    Baker RW; Kinon BJ; Maguire GA; Liu H; Hill AL
    J Clin Psychopharmacol; 2003 Aug; 23(4):342-8. PubMed ID: 12920409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine in ED patients: differential effects on oxygenation in patients with alcohol intoxication.
    Wilson MP; Chen N; Vilke GM; Castillo EM; MacDonald KS; Minassian A
    Am J Emerg Med; 2012 Sep; 30(7):1196-201. PubMed ID: 22633728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole.
    Thone J
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):481-2. PubMed ID: 18070865
    [No Abstract]   [Full Text] [Related]  

  • 25. Olanzapine in the treatment of agitation in hospitalized patients with schizophrenia and schizoaffective and schizofreniform disorders.
    Turczyński J; Bidzan L; Staszewska-Małys E
    Med Sci Monit; 2004 May; 10(5):PI74-80. PubMed ID: 15114282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of molindone in treatment-refractory agitated schizophrenia: three case reports.
    Ciranni M; Lindenmayer JP; Gold J
    J Clin Psychiatry; 2008 Jun; 69(6):1018-9. PubMed ID: 18684000
    [No Abstract]   [Full Text] [Related]  

  • 27. Old drug in new package promises to calm the agitated.
    Morrow T
    Manag Care; 2014 Apr; 23(4):50-1. PubMed ID: 24864536
    [No Abstract]   [Full Text] [Related]  

  • 28. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
    Andrezina R; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; McQuade RD
    Curr Med Res Opin; 2006 Nov; 22(11):2209-19. PubMed ID: 17076982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
    Daniel DG; Currier GW; Zimbroff DL; Allen MH; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
    J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
    Zimbroff DL; Marcus RN; Manos G; Stock E; McQuade RD; Auby P; Oren DA
    J Clin Psychopharmacol; 2007 Apr; 27(2):171-6. PubMed ID: 17414241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic restlessness with antipsychotics.
    Bratti IM; Kane JM; Marder SR
    Am J Psychiatry; 2007 Nov; 164(11):1648-54. PubMed ID: 17974927
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of the agitated patient. A pharmacological update.
    McGough JJ; Bona JR
    N C Med J; 1988 Oct; 49(10):497-9. PubMed ID: 2903452
    [No Abstract]   [Full Text] [Related]  

  • 33. Agitation in schizophrenia: origins and evidence-based treatment.
    Citrome L
    Curr Opin Psychiatry; 2021 May; 34(3):216-221. PubMed ID: 33395103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical perspectives on atypical antipsychotics for treatment of agitation.
    Caine ED
    J Clin Psychiatry; 2006; 67 Suppl 10():22-31. PubMed ID: 16965192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
    J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents.
    Khan SS; Mican LM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):671-7. PubMed ID: 17201611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intramuscular olanzapine: a review of its use in the management of acute agitation.
    Wagstaff AJ; Easton J; Scott LJ
    CNS Drugs; 2005; 19(2):147-64. PubMed ID: 15697328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pisa syndrome resolved after switching to olanzapine.
    Nishimura K; Mikami Y; Tsuchibuchi S; Horikawa N
    J Neuropsychiatry Clin Neurosci; 2007; 19(2):202-3. PubMed ID: 17431077
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.
    Meehan KM; Wang H; David SR; Nisivoccia JR; Jones B; Beasley CM; Feldman PD; Mintzer JE; Beckett LM; Breier A
    Neuropsychopharmacology; 2002 Apr; 26(4):494-504. PubMed ID: 11927174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled loxapine: a new treatment for agitation in schizophrenia or bipolar disorder.
    Owen RT
    Drugs Today (Barc); 2013 Mar; 49(3):195-201. PubMed ID: 23527323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.